Pharmaceutical R-Pharm, one of Russia’s leading drugmakers, together with the USA’s AbbVie have won a tender for the supply of one of the most sought after anti-HIV drugs – Kaletra (lopinavir plus ritonavir) for the needs of the state, according to the company and the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. 5 July 2018